Evidence map›Paper›PMID 28135837›Full record

ArticleClinical trials (London, England)2017

Rejoinder.

Thomas R Fleming, David L DeMets, Matthew T Roe, Janet Wittes, Karim A Calis, Amit N Vora, Alan Meisel, Raymond P Bain, Marvin A Konstam, Michael J Pencina and 8 more

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical trials (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Thomas R Fleming1 Department of Biostatistics, University of Washington, Seattle, WA, USA.
David L DeMets2 University of Wisconsin, Madison, WI, USA.
Matthew T Roe3 Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Janet Wittes4 Statistics Collaborative, Inc., Washington, DC, USA.
Karim A Calis5 Center for Drug Evaluation and Research, U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA.
Amit N Vora3 Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
Alan Meisel7 University of Pittsburgh, Pittsburgh, PA, USA.
Raymond P Bain8 Merck Research Laboratories, North Wales, PA, USA.
Marvin A Konstam9 Tufts Medical Center, Boston, MA, USA.
Michael J Pencina3 Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.
David J Gordon10 National Heart, Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, USA.
Kenneth W Mahaffey11 Stanford University School of Medicine, Stanford, CA, USA.
Charles H Hennekens12 Florida Atlantic University, Boca Raton, FL, USA.
James D Neaton13 University of Minnesota, Minneapolis, MN, USA.
Gail D Pearson10 National Heart, Lung and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, USA.
Tomas Lg Andersson14 AstraZeneca, Mölndal, Sweden.
Marc A Pfeffer15 Brigham and Women's Hospital, Boston, MA, USA.
Susan S Ellenberg16 University of Pennsylvania, Philadelphia, PA, USA.

Funding

STATISTICAL ISSUES IN AIDS RESEARCHR37AI029168 · NIAID · UNIVERSITY OF WASHINGTON · PI JAMES P HUGHES · 1999 to 2026
$9.8M
STATISTICAL ISSUES IN AIDS RESEARCHR01AI029168 · NIAID · UNIVERSITY OF WASHINGTON · PI HUGHES, JAMES P · 1989 to 2018
$5.3M
NIAID NIH HHS R37 AI029168
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Advisory CommitteesClinical Trials Data Monitoring CommitteesResearch Design

Identifiers

PMID28135837
PMCPMC5376229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.